Aortic or Mitral Valve Replacement With the Biocor and Biocor Supra

NACompletedINTERVENTIONAL
Enrollment

297

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

October 31, 2015

Study Completion Date

March 31, 2016

Conditions
Aortic Valve InsufficiencyAortic Valve RegurgitationAortic Valve StenosisAortic Valve IncompetenceMitral Valve InsufficiencyMitral Valve RegurgitationMitral Valve StenosisMitral Valve Incompetence
Interventions
DEVICE

Biocor and Biocor Supra valves

Replacement for a diseased, damaged, malformed aortic or mitral heart valve

Trial Locations (17)

17033

Penn State Milton S. Hershey Medical Center, Hershey

19104

Hospital of the University of Pennsylvania, Philadelphia

23507

Sentara Norfolk General Hospital/Sentara Heart Hospital, Norfolk

37205

Saint Thomas Hospital, Nashville

37660

Wellmont Holston Valley Medical Center, Kingsport

44195

Cleveland Clinic Foundation, Cleveland

46240

Indiana Heart Hospital, Indianapolis

47710

The Heart Group, PC, Evansville

55102

HealthEast St. Joseph Hospital, Saint Paul

64111

St. Luke's Hospital, Kansas City

90033

USC University Hospital, Department of Cardiothoracic Surgery, Los Angeles

92103

Scripps Green Hospital/Scripps Clinic, La Jolla

97225

Providence St. Vincent Medical Center, Portland

04102

Maine Medical Center, Portland

03102

Catholic Medical Center, Manchester

08903

Robert Wood Johnson Medical School, New Brunswick

07450

Valley Hospital, Ridgewood

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT00636987 - Aortic or Mitral Valve Replacement With the Biocor and Biocor Supra | Biotech Hunter | Biotech Hunter